Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

AstraZeneca’s Brilinta – Treatment for Acute Coronary Syndrome

AstraZeneca developed the drug, which was approved for use in Canada in June 2011.

Go Top